Thor Medical ASA (OSL: TRMED)
1.018
-0.006 (-0.59%)
Aug 30, 2024, 4:25 PM CET
Thor Medical ASA Company Description
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway.
It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium.
The company was founded in 2009 and is headquartered in Oslo, Norway.
Thor Medical ASA
Country | Norway |
Founded | 2009 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 2 |
CEO | Jasper Kurth |
Contact Details
Address: Karenslyst allé 9C Oslo, 0278 Norway | |
Phone | 47 97 41 40 00 |
Website | thormedical.no |
Stock Details
Ticker Symbol | TRMED |
Exchange | Oslo Børs |
Fiscal Year | January - December |
Reporting Currency | NOK |
ISIN Number | NO0010597883 |
SIC Code | 2836 |